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Abstract

The U.S. military represents a unique population within the human immunodeficiency virus 1 (HIV-1) pandemic. The last comprehensive study of HIV-1 in members of the U.S. Navy and Marine Corps (Sea Services)
was completed in 2000, before large-scale combat operations were taking place. Here, we present molecular
characterization of HIV-1 from 40 Sea Services personnel who were identified during their seroconversion
window and initially classified as HIV-1 negative during screening. Protease/reverse transcriptase ( pro/rt) and
envelope (env) sequences were obtained from each member of the cohort. Phylogenetic analyses were carried out
on these regions to determine relatedness within the cohort and calculate the most recent common ancestor for
the related sequences. We identified 39 individuals infected with subtype B and one infected with CRF01_AE.
Comparison of the pairwise genetic distance of Sea Service sequences and reference sequences in the env and
pro/rt regions showed that five samples were part of molecular clusters, a group of two and a group of three,
confirmed by single genome amplification. Real-time molecular monitoring of new HIV-1 acquisitions in the Sea
Services may have a role in facilitating public health interventions at sites where related HIV-1 infections are
identified.

Introduction

U

NAIDS recognizes military members as a group at
risk of human immunodeficiency virus 1 (HIV-1) infection1 and the U.S. military portion of the HIV-1 pandemic is
unique for several crucial reasons. Screening for anti-HIV-1
antibodies has been employed on all applicants for military
service since 1985 and on active and reserve component
members of the armed services since 1986.2 In 2004, the Department of Defense instituted mandatory testing for all service members every 2 years. Testing is also conducted when
clinically indicated and as related to predeployment and
postdeployment processing.2,3 In addition, U.S. military personnel constitute a globally deployed risk group who are
subject to unique HIV-1 risk environments and the stress of 11

years of continuous large-scale combat and support operations in support of the Global War on Terrorism and Overseas
Contingency Operations, most prominently in Afghanistan
and Iraq.
Several epidemiological and molecular epidemiological
studies of HIV-1 have evaluated incident infections in the U.S.
Army and Air Force with the most recent cohort ending in
2007.4–7 Studies have also been undertaken investigating infections in the U.S. Navy and Marine Corps,8–10 but the most
recent of these considered data through May 2000, before the
beginning of large-scale combat operations. Recent annual
rates of infection per 1,000 HIV-1 tests range from 0.13 to 0.35
depending upon service and component (whether active or
reserve force) in the Sea Services.2,3 Since the tempo of deployments and geographic breadth of missions undertaken by
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the Navy and Marine Corps in the post-9/11 era have significantly increased, important questions remain for epidemiology and prevention.
This current study aims to molecularly characterize acute
and very early incident HIV-1 infections in the U.S. Navy and
Marine Corps with a first known positive HIV-1 screening test
between January 1, 2005 and August 3, 2010.3 The overarching public health investigation and its epidemiology have
been described elsewhere.3
Materials and Methods

Downloaded by Case Western Reserve University from www.liebertpub.com at 12/23/21. For personal use only.

Participants and HIV-1 testing
The overall study was comprised of 496 participants who
are enlisted U.S. Sailors and Marines with a first known
positive HIV-1 screening test between January 1, 2005 and
August 3, 2010.3 From January 2005 through April 2009,
screening utilized the second generation enzyme-linked immunosorbent assay (ELISA) confirmed through Western
blot.3 All 496 participants had their last-negative HIV-1 test
rescreened using the third-generation ELISA confirmed
through Western blot and nucleic acid testing (NAT) using the
Abbott RealTime HIV-1 Test. The subset described in this
publication is comprised of 54 participants whose last negative HIV-1 test occurred during their seroconversion window
where anti-HIV-1 antibody testing was nonreactive but retrospective look back testing of repository samples detected
HIV-1 nucleic acid. The seroconversion window lasts from
approximately 5–19 days postinfection.11 Therefore, these 54
participants were initially misclassified as negative in their
HIV-1 screening. Of the 54 samples drawn during this seroconversion window of the 496 in this cohort, 12 samples were
not available because volumes were entirely consumed during HIV-1 diagnostic look back testing. Sample identification
numbers given to each individual were coded to protect their
personal information.
Viral RNA extraction
A volume of 0.5 ml of plasma was extracted per sample. For
samples with viral load (VL) below 10,000 copies/ml, 1 ml of
plasma was extracted. The plasma was centrifuged for 1 h at
4°C at 20,000 · g. One hundred and forty microliters of plasma
was left behind following the spin. The viral pellet was resuspended and extracted with the QIAamp viral RNA mini
kit (Qiagen, USA) per the manufacturer’s instructions.
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Complementary DNA (cDNA) synthesis
Viral RNA was reverse transcribed using the SuperScript
III RT kit (Invitrogen, USA) following the manufacturer’s instructions. Of oligo(dT) 50 lM was utilized as the primer
along with kit contents diethylpyrocarbonate (DEPC) H2O
and 10 mM deoxynucleotide triphosphates (dNTP). Seven
microliters of RNA was added to the mix and incubated for
5 min at 65°C. A mix of 10 · RT buffer, DTT, MgCl2, RNase
OUT, and SuperScript III RT enzyme was added to the RNA/
primer mix for a total reaction volume of 20 ll. The reaction
proceeded for 3 h at 50°C, followed by 85°C for 5 min. In
some cases, an internal primer (HXB2 5983–5956) was used
to generate the pro/rt cDNA fragment when oligo(dT)generated cDNA was not conducive to yielding a positive
pro/rt polymerase chain reaction (PCR). The cDNA obtained
was used as a template for PCR at near end-point dilution. For
cDNA amplification, the primers used in this study are shown
in Table 1 with the PCR conditions described below.
Pro/rt PCR
The PCR for the pro/rt region (HXB2 2094–3866) utilized the
AmpliTaq Gold PCR kit (Applied Biosystems, USA) per the
manufacturer’s instructions. Briefly, MgCl2, 10 · PCR buffer,
dNTP (1.25 mM), forward and reverse primers (20 lM for each),
and AmpliTaq Gold enzyme were made in a master mix and
dilutions of cDNA were added with water to a final volume of
50 ll. The nested PCR strategy utilized first round PCR primers
at HXB2 positions 1808–1834 and 3892–3870 and second round
PCR primers at HXB2 positions 2071–2093 and 3886–3864.
Env PCR
The PCR for the env region (HXB2 5984–9063) utilized the
Platinum Taq kit (Invitrogen, USA) per the manufacturer’s instructions. Briefly, 10 · buffer, MgSO4, dNTP (1.25 mM), forward and reverse primers (20 lM for each), and Platinum Taq
enzyme were made in a master mix and dilutions of cDNA were
added with water to a final volume of 20 ll. The seminested PCR
strategy utilized the same forward primer in both first and
second round PCR reactions and was positioned at HXB2 5958–
5983. The first round reverse primer was positioned at HXB2
9520–9497 and the second round reverse primer at HXB2 9089–
9064. For samples where a molecular link was observed, SGA
was carried out using the same PCR protocol and the PCR
products from a cut-off of 30% positive wells were used.12

Table 1. List of Primer Sequences Used for Polymerase Chain Reaction
Region (HXB2 number)
pro/rt (2094–3866)

env (5984–9063)

Full genome (789–9,496)

Primer/probe

Sequence (5¢–3¢)

Outer forward
Outer reverse
Inner forward
Inner reverse
Outer + inner forward
Outer reverse
Inner reverse
Outer forward
Outer reverse
Inner forward
Inner reverse

GGGCTTCATTAGAAGAAATGATGACAG
CTATTRGCTGCCCCATCTACATA
GARAGRCAGGCTAATTTTTTAGG
GCTGCCCCATCTACATAGAAAGT
TAGGCATTTCCTATGGCAGGAAGAAG
GCAGCTGCTTATATGCAGGATCTGAGGG
TCCAGTCCCCCCTTTTCTTTTAAAAA
AAATCTCTAGCAGTGGCGCCCGAACAG
GCACTCAAGGCAAGCTTTATTGAGGCTT
TGACTAGCGGAGGCTAGAAGGAGAGA
GCAGCTGCTTATATGCAGGATCTGAGGG
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yielding secondary or nonspecific bands, the NucleoSpin Gel
and PCR Clean-up kit (Macherey-Nagel, USA) was utilized
for gel extraction and purification of PCR products. Sequencing reactions of PCR products were performed using the
BigDye Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems, USA) along with 5 · Sequencing Buffer, and water to
a final volume of 16 ll. Sequencing reactions were purified
with a PCR 96 Well Kit (Princeton Separations, USA) and
loaded on an Applied Biosystems 3730 DNA Analyzer.
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Sequence alignment
Sequences generated from this cohort were manually edited
using Sequencher 5.0 (Gene Codes Corporation, USA) and
aligned using Gene Cutter (HIVDB).13 The initial HIV-1 genotype was assigned for each sequence in this cohort using the
HIV-1 Genotyping Tool at the National Center for Biotechnology Information (NCBI).14 Appropriate reference sequences that
covered the entire region of pro/rt, env, or full-genome were
downloaded from the HIVDB and aligned. The whole alignment covering each region and consisting of sequences from this
cohort plus references was manually edited using MacGDE 2.4.
Phylogenetic analysis

FIG. 1. Consort figure sample selection criteria. Out of the
total cohort of 496 individuals with incident HIV-1 infections, 54 were misclassified as HIV-1 negative in their last
negative screening. These samples were anti-HIV-1 antibody
negative but nucleic acid positive leading to the misclassification of these samples.
Full-genome PCR
The PCR for full-genome sequence generation (HXB2 789–
9496) utilized the Advantage GC Genomic LA kit (Clontech,
USA) per the manufacturer’s instructions. Briefly, 2 · GC-Melt
LA Buffer, dNTP (10 mM), forward and reverse primers (20 lM
for each), and GC Genomic LA polymerase mix were made in a
master mix and dilutions of cDNA were added with water to a
final volume of 25 ll. The nested PCR strategy utilized first
round PCR primers at HXB2 623–649 and 9632–9605 and second
round PCR primers at HXB2 763–788 and 9524–9497.
Sequencing
PCR products generated by the most dilute cDNA for pro/
rt, env, or full-genome sequencing were purified using the
PureLink Genomic DNA Purification kit (Invitrogen, USA)
per the manufacturer’s instructions. For PCR reactions

Reference sequences were comprised of only subtype B for
the pro/rt and env regions and subtype B and CRF01_AE for the
full-genome alignments. A single reference was kept per individual (earliest time point). Reference sequences with excessive
‘‘N’’ base calls and/or containing large insertions or deletions
were removed from the analysis. Alignments for pro/rt, env, and
full-genome regions were phylogenetically analyzed using
Molecular Evolutionary Genetics Analysis (MEGA) 5.0.15 In all
regions, subtype B references belonging to Thai B, termed B¢,
were excluded from analysis since sequences from this cohort
did not belong to B¢. In the pro/rt region, 144 nucleotide positions were removed from analysis due to their association with
drug resistance that may confound the analysis. This comprehensive list of drug resistance sites was taken from the Stanford
University HIV Drug Resistance Database. Maximum likelihood
(ML) analysis was utilized to phylogenetically categorize the
pro/rt and env regions. The ML method used the General Time
Reversible (GTR) substitution model and gaps were treated as
partial deletion with a cutoff of 50% of site coverage. Neighborjoining analysis with the Kimura two-parameter model of
substitution16 was utilized to determine the subtype of the fullgenome sequences. Gaps were also treated as partial deletion
with a cutoff of 50% of site coverage. Phylogenetic trees generated from the analyses were visualized using FigTree 1.3.1.
Pairwise genetic distance analysis
Calculations for pairwise genetic distance of env and pro/rt
regions were performed in MEGA 5.0.15 The Kimura twoparameter substitution model16 was utilized with partial deletion (50%) of gaps. The distance matrix data were analyzed
using JMP Genomics Software 4.0 (SAS Institute Inc., USA).
Inferring most recent common ancestor (MRCA) using
Bayesian Markov chain Monte Carlo (MCMC) relaxed
molecular clock
To determine the time to the MRCA, we used a Bayesian
MCMC-based approach. BEAST version 1.6.2 was used for
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FIG. 2. Maximum likelihood (ML)
phylogenetic trees generated from
pro/rt and env sequencing. ML
phylogenetic tree of the pro/rt region (HXB2 2094–3866) from 1,296
subtype B reference sequences and
39 sequences from this cohort are
shown (A). Five hundred and three
subtype B references and 38 sequences from this cohort were analyzed by ML and covered the env
region (HXB2 5984–9063) (B). The
five samples shown to be part of a
cluster were further sequenced to
generate 10 env SGA sequences per
sample. Red *, cohort sequences;
green *, cohort sequences part of the
dual cluster; blue *, cohort sequences part of the tri cluster; black
box, indicates dual quasispecies.

all calculations.17 SGA sequences generated from the same
individual were grouped into a single taxon to allow for
calculations. Analyses were carried out using the GTR
substitution model and a relaxed uncorrelated exponential
clock17,18 with exponential growth prior. The MRCA calculations reported were based on an ESS of greater than 300
via Tracer version 1.5. Trees generated from the BEAST
runs were visualized after 10% burn-in with TreeAnnotator

version 1.6.2. A graph of the MRCA with 95% confidence
intervals was generated using Prism 5.0 (GraphPad Software, USA).
GenBank submission
The sequences from this study have been submitted to
GenBank under the numbers JX863919–JX864047.
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FIG. 3. Neighbor-joining tree generated from full-genome sequencing.
An alignment was generated covering all gene-coding regions of the
HIV-1 genome (HXB2 789–9496). A
total of 299 subtype B reference sequences was compared alongside the
five linked samples from this cohort.
Additionally, 88 CRF01_AE references and the single CRF01_AE sequences from this cohort are
represented. Red *, CRF01_AE cohort
sequence; green *, cohort sequences
part of the dual cluster; blue *, cohort
sequences part of the tri cluster.

Results
Participants
The Sea Services study identified 496 HIV seroconversions3
and look back testing of the last seronegative sample in each
of these cases showed that 54 were positive by NAT. Twelve
of 54 samples were not available because volumes were entirely consumed during HIV-1 diagnostic look back testing.
Additionally, two samples were not amplifiable either in
protease/reverse transcriptase ( pro/rt) or envelope (env) and
one sample was amplifiable only in pro/rt (Fig. 1). The collection dates ranged from April 5, 2002 to December 21, 2009.
The mean VL for these samples was 6.8 with a range of 3.7 to
7.8 log copies per ml.
HIV-1 subtype designation and cluster identification
Based on sequenced regions of pro/rt and env, 39 of the 40
samples were subtype B while one was CRF01_AE. None of
the subtype B sequences clustered with Thai B, so-called B¢.
We further examined the genetic diversity of the subtype B
sequences with other subtype B reference sequences obtained
from the LANL HIVDB.13 Given that sequences in our cohort
were not classified as B¢, B¢ sequences were excluded from our
analysis.
Thirty-nine sequences from our cohort (red *) and 2,296
pro/rt subtype B references were analyzed by ML (Fig. 2A).
Prior to tree construction, 144 nucleotide positions (48 amino

acids) corresponding to potential drug resistance were considered potentially confounding and were removed from
analysis. Most of the sequences of interest were dispersed
throughout the subtype B reference sequences. However,
there was a group of two samples (green *) [306159, 306512]
and a group of three samples (blue *) [306344, 306376, 306517]
that formed tight monophyletic clusters.
A similar analysis approach was performed on the env sequences. Thirty-eight sequences from our cohort and 538
reference sequences were analyzed in env by the ML method,
confirming the subtypes identified in pro/rt (Fig. 2B). Figure
2B also shows an even distribution of our cohort samples
(red*) throughout the reference sequences. We have employed SGA, a powerful technique that allows the fine analysis of sequence differences. It has been particularly useful in
the analysis of transmitted founder viruses and in the evaluation of breakthrough infections in vaccine studies.19,20 SGA
of env was performed on the five molecularly linked samples.
The generation of multiple sequences from the same patient
for env SGA further strengthens the link within each cluster
and also reveals that 306159 and 306344 have two predominant quasispecies (green or blue * surrounded by a black box)
that were also confirmed by visual inspection and HIVDB
Highlighter Plot (data not shown).13
Furthermore, we obtained full-genome sequences (HXB2
789–9496) of the five samples from these two linked clusters as
well as the single CRF01_AE sequence. Two hundred and
ninety-nine subtype B and 88 CRF01_AE reference sequences
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FIG. 4. Pairwise genetic distance
calculations for the env region. The
pairwise genetic distance for the env
region was calculated for reference
and cohort sequences using the Kimura two-parameter model. For
each figure section, the mean pairwise genetic distance is annotated
in the center of each graph. (A) A
comparison of references and sequences from this cohort; (B) cohort
sequences compared to references
identified prior to the year 2000; (C)
cohort sequences compared to references identified from 2000 to
2004; (D) cohort sequences compared to references identified from
2005 to the present; (E) cohort sequence comparison without any
references.

from the HIVDB were included in the neighbor-joining phylogenetic analysis. In concordance with our previous data, the
clusters were readily apparent over the full genome, and the
CRF01_AE sequence clustered with other CRF01_AE reference sequences identified from Southeast Asia (Fig. 3).

Genetic distance calculations of molecularly
linked samples
We further characterized the relationship of the two molecularly linked groups through comparison of sequence
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diversity of the two groups to the reference sequences, stratified by the following years: pre-2000, 2000–2004, and 2005–
present. Reference sequences that did not have a date were
removed from this analysis.
Initially, we considered the env region since it is more
diverse than pro/rt, thereby providing a greater likelihood to
observe differences between our linked samples and others
from the cohort. For the three sequences suspected to be
molecularly linked and having a single quasispecie, we
generated a consensus sequence of the 10 env SGA obtained
per individual and used each consensus for analysis of the
genetic distance. For the two sequences with dual quasispecies, a separate consensus was generated for each quasispecie such that each of these dually infected individuals
would be represented by two consensus sequences in the
analysis. We chose to use consensus env sequences in the
analysis because we did not want to overemphasize the
signal observed if each of the SGA sequences was used
separately. The overall comparison of Sea Service samples
plus reference sequences showed a mean genetic distance of
0.142 (Fig. 4A). Interestingly, when sequences from this cohort were compared to the references characterized as pre2000, 2000–2004, and 2005–present, a significant increase in
genetic distance was observed from 0.136 to 0.149 to 0.152
( p-values < 0.0001), respectively (Fig. 4B–D). Additionally,
the comparison of cohort sequences to each other, without
references, yielded a mean genetic distance of 0.152 (Fig. 4E).
A comparison of the genetic distances of the consensus sequences from each member of the cluster is shown in Table 2
(top portion). The genetic distance of sequences in the two
molecular clusters was less than 0.025 and well outside of
the bell curve distribution observed in all comparisons,
providing further evidence of the molecular link between
these groups of sequences.
After removal of nucleotide positions associated with drug
resistance, comparison of cohort and reference sequences in
the pro/rt region showed a mean genetic distance of 0.066
(Fig. 5A). In parallel with env data, cohort samples from
pre-2000, 2000–2004, and 2005–present showed a significant
increase in genetic distance from 0.059 to 0.066 to 0.069
( p-values < 0.0001), respectively (Fig. 5B–D). Through comparison between these cohort sequences, the same genetic
distance of 0.069 was observed for reference sequences over
the same time period (Fig. 5E). A comparison of the genetic
distances of the consensus sequences from each member of the
cluster is shown in Table 2 (bottom portion). The genetic
distances of sequences in the two molecular clusters were less
than 0.01 and fall outside the bell curve distribution.
Dating of linked molecular clusters
We used the Bayesian MCMC approach to calculate time to
the MRCA of each linked sample and the overall time to
MRCA for each cluster. All 10 env SGA sequences generated
per individual were used in calculations and grouped as a
single entity. The draw dates for each sample were used in the
MRCA calculation. Additionally, the last negative test dates
(4–18 months, see Table 3) were used as a guide to verify the
MRCA calculations produced in the analysis.
With the dual cluster, 306159 and 306512, there was a large
period of time between the two samples (Fig. 6A and Table 3).
Sample 306512 had a mean MRCA calculation of 0.58 months
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Table 2. Pairwise Genetic Distance
of the Linked Groups
306159_b 306512 306344_b 306376 306517
Env
306159_a
306159_b
306344_a
306344_b
306376
Pro/rt
306159
306344
306376

0.008

0.024
0.024
0.008

0.009
0.010

0.018
0.017
0.014

0.003

0.009
0.008

0.006

The two linked groups and the pairwise genetic distance of the
consensus sequence of each sample within the group are shown. The
top portion of the table shows env distances and the bottom portion
shows pro/rt distances.

(95% upper–lower of 2.0–0.02) while that for 306159 was 53.5
months (95% upper–lower of 56.83–52.05) prior to the 306512
collection date (Fig. 6B). The MRCA of this dual cluster was
calculated to be 56.1 months (95% upper–lower of 65.41–
52.06), in agreement with the last known negative HIV-1 test
for each individual (Table 3).
The cluster of three sequences, 306344, 306376, and 306517,
had a shorter time period between samples, including two test
dates within 3 months (Fig. 6C and Table 3). Sequence 306517
had a mean MRCA of 0.47 (95% upper–lower of 1.26–0.04),
306376 of 30.38 (95% upper–lower of 30.94–30.03), and 306344
of 34.32 months (95% upper–lower of 36.34–33.16) prior to the
306517 collection date (Fig. 6D). Overall, this cluster had an
MRCA date of 34.41 months (95% upper–lower of 36.49–
33.18), consistent with the last known negative HIV-1 test
(Table 3).
Discussion
Using samples from enlisted U.S. Navy and Marine Corps
personnel whose first known positive HIV-1 screening test
occurred between January 1, 2005 and August 3, 2010, we
characterized sequences from 40 of 54 cohort members with
samples drawn in the seroconversion window. Non-B subtypes, including recombinant viruses, have been identified
previously in U.S. military cohorts.7–10 In this study, all but
one sequence in this cohort was subtype B, suggesting that 11
years of continuous large-scale combat and support operations has not significantly altered the HIV-1 subtypes previously reported to be circulating in Sea Services personnel.8–10
The sequencing of two regions of the HIV-1 genome increased the likelihood of correct subtype designation. While
linkage analysis did not change in this study from the use of
two regions, others have used a similar strategy of sequencing
multiple HIV-1 genes and have found this to be an effective
tool to characterize transmission groups.21–25 The use of ML
phylogenetic analysis was one method used to identify
transmission clusters, but we also employed the calculation of
the pairwise genetic distance over the pro/rt and env regions.22 Comparing the genetic distance of our linked samples
to all subtype B reference sequences spanning the same regions, we observed that the genetic distance of our linked
samples was below the mean distance of all reference
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FIG. 5. Pairwise genetic distance
calculations for the pro/rt region.
The pairwise genetic distance for
the pro/rt region was calculated for
reference sequences and cohort sequences using the Kimura two-parameter model. For each figure
section, the mean pairwise genetic
distance is annotated in the center
of each graph. (A) A comparison of
references and cohort sequences;
(B) cohort compared to references
identified prior to the year 2000; (C)
cohort sequences compared to references identified from 2000 to
2004; (D) cohort sequences compared to references identified from
2005 to the present; (E) cohort sequence comparison without any
references.

sequences compared. Our group of two (306159 and 306512)
and three (306344, 306376, and 306517) linked samples was
separated by years between diagnoses. Samples 306159 and
306512 are separated by more than 4 years while 306344 and
306376 are separated by 3 months and 306376 and 306517 by

more than 2 years. These data are consistent with the findings
of Redd et al.,26 who reported that transmitted viruses more
closely resemble donor archival sequences than the diverse
quasispecies observed in the donor prior to transmission. This
further supports the idea that unique features of transmitted
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Table 3. Dates of Importance for the Linked Samples
Spin
number

Last
negative
test date

First
positive
test date

Calculated
HIV-1
acquisition date

306159
306512
306344
306376
306517

24-Feb-2004
15-Apr-2009
18-May-2006
14-Dec-2005
22-Aug-2009

14-Apr-2005
20-Aug-2009
09-Mar-2007
04-Jun-2007
21-Dec-2009

08-Mar-2005
03-Aug-2009
12-Feb-2007
30-May-2007
07-Dec-2009
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Important dates associated with the five samples demonstrated to
be molecularly linked. The last negative HIV-1 test date for each
individual is given along with the first positive test date, which is the
collection date of the sequences described here. The approximate
acquisition date based on Bayesian MCMC analysis is also shown.

founder viruses are required to overcome the transmission
bottleneck.27,28
Even in the setting of short transmission periods, distinguishing between common or linked sources is problematic.29,30
To determine direction of transmission through these methods

would require multiple samples taken before and after infection
for each individual in the transmission cluster.29 This is not
feasible in a force-wide screening program. A convenience survey of a subgroup of this cohort revealed several self-identified
risk factors including multiple and varied sexual exposures
during the risk window,31 further complicating any such
determination. However, these methods combined with conventional epidemiologic approaches could provide strong
transmission information relevant to public health.
Bayesian MCMC calculation for the time to the MRCA of
each sample agrees with the initial date of diagnosis regarding
which individual was diagnosed before another in each
cluster. It is not known if others are involved in each network/
cluster, either from the larger group of samples from this cohort that were not analyzed3 or part of the civilian population
that interacts with this cohort. In addition, two samples,
306196 and 306501, whose genetic distance calculations to
each other were relatively low, 0.074 for env and 0.035 for pro/
rt, were characterized as unlinked because the genetic distance between the two sequences in env and pro/rt fall within
the bell curve distribution of all reference sequences for each

FIG. 6. Relaxed-clock use for
cluster analysis. The most recent common ancestor (MRCA)
was calculated for each of the
linked clusters using a Bayesian
Markov chain Monte Carlo
(MCMC)-based approach on
the env region. The date of
sample collection was used in
the calculation of the MRCA.
The dual cluster (306159,
306512) MCMC-based consensus tree is calibrated to the time
prior to the 306512 collection
date (A). A graphic representation, including the upper and
lower 95% confidence interval
for MRCA of each sample and
the cluster as a whole, is shown
(B). The tri cluster (306344,
306376, 306512) MCMC-based
consensus tree is calibrated to
the time prior to the 306517
collection date (C). A graphic
representation, including the
upper and lower 95% confidence interval for MRCA of
each sample and the cluster as a
whole, is shown (D).
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region, as shown in Figs. 4A and 5A. A bridging sample
was not identified in this subgroup of seroconversion, earlyincident infections within this cohort.
A second observation made during this ancestor analysis
was that the mean genetic distance of sequences from this
cohort compared to reference sequences increased over the
time period evaluated: pre-2000, 2000–2004, and 2005–present
(Figs. 4B–D and 5B –D, respectively). Previous studies reported that HIV-1 genetic diversity increases by approximately 1% per year32,33 due to its high mutation rate.34 Therefore,
it is not unexpected that HIV-1 genetic diversity within subtype B increases over time. In fact, others have made similar
observations with HIV-1 subtype B and C through comparison of the gag and env genes.35 Taken together with previous
observations regarding HIV-1 diversity increase over time,
acquired subtype B HIV-1 in this cohort continues to be part of
the larger HIV-1 epidemic rather than comprising an isolated
network of transmitted viruses (compare Figs. 4D and E and
5D and E).
Among these 40 analyzed sequences, five (12.5%) were
linked. While patients identified in the seroconversion window may differ from the overall cohort for a number of reasons including risk behavior prompted self-referral for
testing, extrapolating to the entire cohort of Sailors and
Marines in the parent public health investigation, as many as
62 individuals may have acquired linked HIV-1 viruses.
While this would represent a minority of new HIV-1 infections in this cohort, minimizing the number of individuals
who are part of transmission clusters is essential. More analysis is needed to incorporate chronic infections in such analyses, particularly ones identified in similar time frames and at
the same locations as seroconverting infections. This would
allow more robust mapping and characterization of transmission networks to include identification of persistent,
common transmission nodes.
Previous studies have shown that HIV-1 transmission
outbreaks often occur over a limited time frame21,30,36 and
early identification of transmission groups would aid in the
design of specific public health interventions to prevent future
spread. A previous publication highlighted the use and potential positive impact of molecular surveillance on control of
HIV-1 spread within targeted populations.37 While care must
be taken to protect personal confidentiality, real-time identification of transmission networks within the U.S. military may
enhance public health interventions against HIV-1 transmission in the force and is an area of need for further study. Realtime molecular surveillance of HIV-1 acquisition in the U.S.
military should be evaluated for its potential public health
impact.
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